Hangzhou-based Med Vision, a provider of virtual reality (VR)-enabled digital therapeutics (DTx) solutions, has reportedly received a Category II medical device approval in China for its sleep disorder assisted treatment software. This marks a significant milestone as it is the first VR-based sleep disorder device to be approved both in China and globally.
The Impact of VR on Sleep Disorders
The product leverages the power of virtual reality to regulate the autonomic nervous system through visual and auditory stimuli within virtual scenes. By inducing positive emotions and relaxation experiences, it aims to reduce the level of physical and cognitive arousal that typically interferes with sleep. The software provides subconscious cues through relaxation and hypnosis guidance, which can alter negative cognition and emotions that affect sleep, ultimately achieving the effect of treating insomnia.
How the Treatment Works
The VR technology employed by Med Vision’s software works by immersing users in a controlled environment that can help to alleviate the stress and anxiety that contribute to sleep disorders. By guiding users through relaxation techniques and hypnotic suggestions within the VR experience, the software can help to retrain the brain to associate bedtime with relaxation rather than stress, leading to improved sleep quality and potentially curing insomnia.
Conclusion
The approval of Med Vision’s sleep disorder treatment software signifies a new era in the application of VR technology within the healthcare sector. It highlights the potential of digital therapeutics to offer innovative solutions for conditions that have traditionally been challenging to treat, and it paves the way for further exploration of VR in the management of various health issues.-Fineline Info & Tech
